2023Highlights

2023 was a productive year for OSE with 9 new spinouts launched, 32 additional companies financed and significant momentum across our portfolio of Deep Tech, Life Sciences and Health Tech.

Our team of experienced investors and company builders continued to grow as we welcomed Ed Bussey as our new CEO and introduced the position of Chief Investment Officer, appointing Jack Edmondson.

We continue to work with our partners and co-investors to build a vibrant spinout ecosystem in Oxford.

Read on for a selection of 2023 highlights...

What people are saying

Top investor of women-powered businesses

Jpm beauhurst

Top Investor in UK university spinouts

Beauhurst

Top 10 most active investors in European biotechs

Biocentury

FOUND

Driving the development of

Next-generation hardware supporting the AI revolution

Novel therapies for cancer, rare, and retinal diseases

New approaches to clean energy

Digital tools for better drugs and health outcomes

FUND

Raised across the portfolio: £148m from OSE, and £220m+ from UK and international co-investors. New investments in two later-stage companies.

  • PC Wx C o U0 X w S3y GRCJ Cc Lr I Hgw Z8 BZ Ukes Xk C2w5 UU
  • M0 D Is X7 O Pjc VP Bty J2x0 D So J Wz R3 Hwgec Sn Bril Sx I

BUILD